全文获取类型
收费全文 | 21568篇 |
免费 | 2978篇 |
国内免费 | 472篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 365篇 |
妇产科学 | 292篇 |
基础医学 | 882篇 |
口腔科学 | 268篇 |
临床医学 | 4457篇 |
内科学 | 2399篇 |
皮肤病学 | 304篇 |
神经病学 | 858篇 |
特种医学 | 502篇 |
外国民族医学 | 1篇 |
外科学 | 1492篇 |
综合类 | 1955篇 |
一般理论 | 4篇 |
预防医学 | 3672篇 |
眼科学 | 245篇 |
药学 | 5325篇 |
50篇 | |
中国医学 | 1327篇 |
肿瘤学 | 513篇 |
出版年
2024年 | 79篇 |
2023年 | 728篇 |
2022年 | 800篇 |
2021年 | 1481篇 |
2020年 | 1534篇 |
2019年 | 1390篇 |
2018年 | 1320篇 |
2017年 | 1297篇 |
2016年 | 1225篇 |
2015年 | 1160篇 |
2014年 | 1831篇 |
2013年 | 2359篇 |
2012年 | 1510篇 |
2011年 | 1332篇 |
2010年 | 1075篇 |
2009年 | 958篇 |
2008年 | 842篇 |
2007年 | 766篇 |
2006年 | 694篇 |
2005年 | 553篇 |
2004年 | 376篇 |
2003年 | 294篇 |
2002年 | 281篇 |
2001年 | 228篇 |
2000年 | 153篇 |
1999年 | 100篇 |
1998年 | 108篇 |
1997年 | 66篇 |
1996年 | 85篇 |
1995年 | 63篇 |
1994年 | 44篇 |
1993年 | 30篇 |
1992年 | 49篇 |
1991年 | 31篇 |
1990年 | 23篇 |
1989年 | 19篇 |
1988年 | 17篇 |
1987年 | 19篇 |
1986年 | 18篇 |
1985年 | 17篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1972年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
基于RFID的病人用药安全管理新技术探讨 总被引:1,自引:0,他引:1
目前,我国在病人用药安全方面存在的主要问题是:病人本人用药安全意识淡漠、政府和卫生机构管理乏力、医院内部管理不规范、缺乏合适且有效的高新技术的支持。针对这些问题,提出基于先进的RFID技术的病人用药安全管理的新技术和解决方案,从而提高病患在用药过程中的安全系数,辅助相关医疗管理人员对药物进行准确有效的使用,防止用药安全事故的发生。 相似文献
102.
103.
104.
105.
M. OIKKONEN H. HEINE U. SALMINEN O. ROMPPANEN P. INBERG 《Acta anaesthesiologica Scandinavica》1994,38(3):214-217
Peroral dixyrazine (15–30 mg, n = 50) and diazepam (4–10 mg, n = 50) were used as premedicants for geriatric patients having cataract surgery under regional block. Compared to the diazepam patients, a larger number of the dixyrazine medicated patients appeared anxious, and there was a statistically significant difference between the groups, when summing up changes in anxiety throughout the study period. The dixyrazine patients needed more frequent supplementation with intravenous sedative drugs, compared with their diazepam counterparts. Peroral dixyrazine is an applicable choice for calm patients, when only slight sedation, or avoidance of somnolence are required. 相似文献
106.
Dieter Ulrich Preiss Delawer Abdullah Bruno Eberspcher Karlheinz Wilhelm 《Thrombosis research》1992,65(6):677-686
In a prospective clinical trial the risk of infection after application of virus inactivated antithrombin III concentrate ANTITHROMBIN III IMMUNO (AT III) was investigated in patients undergoing cardiovascular surgery. The study was conducted according to the recommendations of the International Committee on Thrombosis and Hemostasis (ICTH), with the exception that most patients required additional blood products as well as AT III.
Twenty-seven patients were eligible to test for the risk of acquiring hepatitis B. Twenty-six patients could be evaluated in terms of hepatitis NANB transmission considering ALT-levels whereas 20 patients could be tested for anti-HCV one year after surgery. Samples from 78 patients could be monitored for anti-HIV-1. None of these patients showed any signs of infection. AT III IMMUNO seems to be an antithrombin III concentrate with low or absent infectivity. 相似文献
107.
Spartaco Bellomo 《Emerging infectious diseases》2005,11(6):985-987
108.
Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment 总被引:4,自引:4,他引:0
Wu-chun Cao Catharina P. B. Van der Ploeg Anton P. Plaisier I. J. Sivera van der Sluijs J. Dik F. Habbema 《Tropical medicine & international health : TM & IH》1997,2(4):393-403
Summary The efficacy and safety of ivermectin in the treatment of filariasis due to Wuchereria bancrofti was assessed by a meta-analysis of the results from 15 published clinical trials. Seven hundred and forty-eight microfilaraemic patients were enrolled in 7 dose-finding and 8 comparative studies. Administered as a single dose, ivermectin induced nearly complete clearance of microfilariae from the blood from the first day to 30 days post-treatment, followed by gradual recurrence of microfilaraemia and increase in its intensity. Higher doses of ivermectin showed greater clearance effects and maintained lower microfilaraemia levels for a longer time. The adverse reactions caused by the drug were flu-like, transient, generally mild and well tolerated by patients. The frequency and intensity of adverse reactions were strongly associated with pretreatment microfilaria counts in the blood, but independent of dose. The findings of the meta-analysis suggest that ivermectin given at a single annual dose of 200 μg/kg body weight or higher, whether or not in combination with DEC, has great potential for therapeutic strategies to control bancroftian filariasis. 相似文献
109.
110.
O. Z. Roy A. J. Mortimer B. J. Trollope E. J. Villeneuve 《Medical & biological engineering & computing》1984,22(3):225-228
Cardiac stimulation thresholds of short-duration large-amplitude electrical transients were studied. An isolated rabbit heart
model was used and transients were applied directly to the heart through electrodes of 1 mm2 and 1 cm2 surface area. A variety of oscillatory waveforms and pulse configurations were studied and indicated that, for transients
shorter than 100 μs, stimulation thresholds approach a constant charge-transfer density of 3·4 μC cm−2. 相似文献